OptiNose Ownership
| OPTN Stock | USD 5.88 0.52 9.70% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 10 M | Current Value 12 M | Avarage Shares Outstanding 4.8 M | Quarterly Volatility 2.5 M |
OptiNose |
OptiNose Stock Ownership Analysis
About 73.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.35. OptiNose had not issued any dividends in recent years. The entity had 1:15 split on the 31st of December 2024. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people. To find out more about OptiNose contact Peter Miller at 267 364 3500 or learn more at https://www.optinose.com.Besides selling stocks to institutional investors, OptiNose also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different OptiNose's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align OptiNose's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
OptiNose Quarterly Liabilities And Stockholders Equity |
|
OptiNose Insider Trades History
About 7.0% of OptiNose are currently held by insiders. Unlike OptiNose's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against OptiNose's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of OptiNose's insider trades
OptiNose Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OptiNose is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OptiNose backward and forwards among themselves. OptiNose's institutional investor refers to the entity that pools money to purchase OptiNose's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 86.2 K | Rice Hall James & Associates, Llc | 2024-12-31 | 74.5 K | Gmt Capital Corp | 2024-12-31 | 74 K | Susquehanna International Group, Llp | 2024-12-31 | 68.5 K | Prescott Group Capital Management Llc | 2024-12-31 | 60.1 K | Blackrock Inc | 2024-12-31 | 55.9 K | Prudential Investment Management Inc | 2024-09-30 | 49.2 K | Easterly Investment Partners. | 2024-12-31 | 46.7 K | Jane Street Group Llc | 2024-12-31 | 28.6 K | Fmr Inc | 2024-12-31 | 1.1 M | Nantahala Capital Management, Llc | 2024-12-31 | 986 K |
OptiNose Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OptiNose insiders, such as employees or executives, is commonly permitted as long as it does not rely on OptiNose's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OptiNose insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
OptiNose Outstanding Bonds
OptiNose issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OptiNose uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OptiNose bonds can be classified according to their maturity, which is the date when OptiNose has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US68404LAA08 Corp BondUS68404LAA08 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
OptiNose Corporate Filings
F4 | 4th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
8K | 15th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of December 2024 Other Reports | ViewVerify |
Pair Trading with OptiNose
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OptiNose position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will appreciate offsetting losses from the drop in the long position's value.Moving together with OptiNose Stock
Moving against OptiNose Stock
| 0.61 | VALN | Valneva SE ADR Earnings Call Tomorrow | PairCorr |
| 0.4 | DVAX | Dynavax Technologies | PairCorr |
| 0.32 | SRZNW | Surrozen Warrant | PairCorr |
The ability to find closely correlated positions to OptiNose could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OptiNose when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OptiNose - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OptiNose to buy it.
The correlation of OptiNose is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OptiNose moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OptiNose moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OptiNose can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.35) | Revenue Per Share | Quarterly Revenue Growth 0.031 | Return On Assets | Return On Equity |
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.